TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 2 | 4 | 5 | -71 | -67 | -80 | -35 |
| S | %wins | 50 | 50 | 50 | 100 | 100 | 100 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/29/14 17:37 | 8/27/14 | SNSS | Sunesis Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Growth Equity Opportunities Fund, LLC | MD | T | S.m | -2,127 | 7.97 | 1 | -267 | -5 | 4,659 | D | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 | |
8/12/14 17:39 | 8/8/14 | SNSS | Sunesis Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Growth Equity Opportunities Fund, LLC | MD | T | S.m | -4,709 | 6.63 | 1 | -711 | -13 | 4,926 | D | 129 | 38 | 45 | 45 | 6 | 18 | 5 | -1 | 4 | 12 | 9 | -74 | -65 | -79 | |
3/14/11 13:59 | 3/10/11 | ARYX | Aryx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Growth Equity Opportunities Fund, LLC | MD | T | S | -326 | 0.0730 | 0 | -4,469 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |